Skip to main content
. 2002 Nov;70(11):6373–6382. doi: 10.1128/IAI.70.11.6373-6382.2002

FIG. 6.

FIG. 6.

Disease progression in mice infected subcutaneously with SA564 or SA564-acnA::ermB. Ten outbred, immunocompetent, hairless mice (Crl::SKH1-hrBR) were inoculated subcutaneously with 3 × 107 CFU of SA564 or SA564-acnA::ermB. Disease progression was followed for 18 days, and representative results are shown.